Attached files
| file | filename |
|---|---|
| EX-99.1 - PHMD_LCA INVESTOR PRESENTATION - Gadsden Properties, Inc. | ex99_1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 14, 2013
PhotoMedex, Inc.
(Exact Name of Registrant Specified in Charter)
|
Nevada
(State or Other
Jurisdiction of
Incorporation)
|
0-11635
(Commission File
Number)
|
59-2058100
(I.R.S. Employer
Identification No.)
|
|
100 Lakeside Drive, Suite 100, Horsham, Pennsylvania
|
19044
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: 215-619-3600
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD
On February 13, 2014, PhotoMedex, Inc. (NasdaqGS and TASE: PHMD), a Nevada corporation (“PhotoMedex”), and LCA-Vision Inc. (NasdaqGS: LCAV), a Delaware corporation (“LCA-Vision”), issued a joint press release announced the signing of a definitive agreement under which PhotoMedex will acquire LCA-Vision. That press release was included as an exhibit to a Form 8-K filed on that date.
PhotoMedex and LCA-Vision held a conference call on February 14, 2014 to discuss this transaction and respond to investor questions concerning it. The presentation materials from that call are furnished as Exhibit 99.1 to this Form 8-K.
PhotoMedex is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. LCA-Vision Inc. is a leading provider of laser vision correction services under the LasikPlus brand.
ITEM 9.01 Financial Statements and Exhibits.
(d) EXHIBITS.
|
99.1
|
PhotoMedex, Inc. Investor Presentation dated February 14, 2014
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.
|
PHOTOMEDEX, INC.
|
||||
|
Date:
|
February 14, 2014
|
By:
|
/s/ Dolev Rafaeli
|
|
|
Dolev Rafaeli
|
||||
|
Chief Executive Officer
|
||||